VWR (NASDAQ: VWR), a leading, independent provider of laboratory products, services and solutions, announced today the expansion of its distribution agreement with New England Biolabs®, Inc. (NEB®). This agreement allows VWR increased access to NEB's growing product portfolio and renowned technical support in the U.S. and Puerto Rico. In addition, customers will now have access to NEB's products through VWR's e-business platform, sales organization, and VWRCATALYST, our onsite services organization.
Established in the mid 1970's, NEB an industry leader in the discovery and production of enzymes for molecular biology applications, now offers one of the largest selections of recombinant and native enzymes for genomic research. NEB continues to develop solutions to support research, most recently including developments in genome editing, synthetic biology and next generation sequencing. Demonstrating a strong commitment to the scientific community, NEB products will continue to be available direct through NEB and now additionally and proudly available through VWR.
"The support and reach of VWR's sales team will help showcase our expanding portfolio of innovative products to a larger number of researchers," said Andrew Bertera, NEB Executive Director of Marketing. "We are excited about the expanded access and ease of ordering this will provide to customers."
"The combined commitment of VWR and NEB to customer solutions and quality products will be of great value to organizations in the life science industry," said Stephan Labonte, Senior Vice President of Marketing for VWR. "We are pleased to offer our customers access to an expanded offering, continuing our mission to provide product choice and unparalleled service to help enable science."
New England Biolabs releases Q5 High-Fidelity DNA Polymerase